Table 2.
Dermatologic Life Quality Index scores according to clinical characteristics
| Total |
Cancer type |
|||||||
|---|---|---|---|---|---|---|---|---|
| Breast cancer |
Colorectal cancer |
Other cancer |
||||||
| DLQI | p-value | DLQI | p-value | DLQI | p-value | DLQI | p-value | |
| Sex | ||||||||
| Male | 2.94±0.36 | 0.006 | 3.43±0.54 | 0.840 | 2.61±1.49 | 0.585 | ||
| Female | 4.42±0.40 | 5.16±0.54 | 3.25±0.68 | 3.15±0.95 | ||||
| Age (yr) | ||||||||
| < 60 | 4.01±0.37 | 0.374 | 5.13±0.57 | 0.861 | 2.37±0.43 | 0.024 | 3.14±0.77 | 0.470 |
| ≥ 60 | 3.51±0.42 | 5.41±1.56 | 4.23±0.69 | 2.49±0.52 | ||||
| Current chemotherapy | ||||||||
| Non-targeted agents only | 3.45±0.33 | 0.046 | 4.72±0.61 | 0.145 | 2.86±0.53 | 0.120 | 2.49±0.49 | 0.335 |
| Any targeted agents | 4.69±0.54 | 6.55±1.14 | 4.25±0.70 | 3.43±0.92 | ||||
| Duration of current chemotherapy (wk)a) | ||||||||
| ≤ 12 | 3.01±0.42 | 3.54±0.77 | 2.54±0.61 | 3.02±0.78 | ||||
| 13-24 | 4.15±0.52 | 4.71±0.75 | 3.67±0.94 | 3.64±1.10 | ||||
| ≥ 25 | 4.36±0.52 | 0.019 | 7.20±1.17 | 0.010 | 4.08±0.73 | 0.066 | 1.94±0.47 | 0.863 |
| Radiotherapy history | ||||||||
| Yes | 4.74±0.71 | 0.100 | 7.95±1.36 | 0.011 | 2.50±1.11 | 0.357 | 2.90±0.83 | 0.817 |
| No | 3.48±0.28 | 4.12±0.50 | 3.53±0.46 | 2.68±0.51 | ||||
Values are presented as mean±standard error. DLQI, Dermatologic Life Quality Index.
a)
Jonckheere-Terpstra test was performed to find the correlation between the duration of anticancer therapy and DLQI scores. Student’s t-test was performed for other variables.